Leading Pharmaceutical Communication Executives Gather for the 1st Annual Pharmaceutical Public Relations... (/p About ExL Pharma ExL Pharma a di...)

Leading Pharmaceutical Communication Executives Gather for the 1st Annual Pharmaceutical Public Relations Symposium

Date:10/8/2007

/p>

About ExL Pharma

ExL Pharma, a division of ExL Events, Inc., is an emerging leader in developing innovative, educational events that serve the healthcare community and allied professionals. Behind our diverse conference portfolio, our experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality conference events designed to exceed the dynamic informational needs of the healthcare community. ExL Pharma is well known as the provider of the PR & Communications Summit for Pharmaceutical, Biotech and Medical Technology, which is scheduled for its 4th run on July 14-15, 2008.

About the Public Relations Society of America (PRSA)

The Public Relations Society of America (http://www.prsa.org), headquartered in New York City, is the world's largest organization for public relations professionals with nearly 32,000 professional and student members. PRSA is organized into 109 Chapters nationwide and 20 Professional Interest Sections and Affinity Groups, which represent business and industry, counseling firms, independent practitioners, military, government, associations, hospitals, schools, professional services firms and nonprofit organizations. The Public Relations Student Society of America (PRSSA) has 285 Chapters at colleges and universities throughout the United States.

About Cision:

Cision, formerly known as Bacon's, Delahaye and multivision, delivers the insight and media intelligence that improves communication performance and builds reputations. As a leading global provider of media research, distribution, monitoring and evaluation services, we ensure consistent global service; with the resources needed to grow with our clients and the public relations profession.

SOURCE ExL Pharma
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Visions, Part II: Preizler sees IT leading incremental health system change
2. Waisman director leading early stages of the Wisconsin Institutes for Discovery
3. NimbleGen partners with leading researchers
4. Leading global Big Pharma companies of 2005
5. Leading cancer institute to install three TomoTherapy systems
6. The worlds leading biotech companies
7. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
8. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
9. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
10. Deltanoid Pharmaceuticals begins phase II osteoporosis study
11. Doing the pharmaceutical tango

Post Your Comments:

(Date:12/15/2009)... -- , - 45 ... Ability of,Cardiopoietic Cells to Restore Cardiac Function ,, ... Belgian biotechnology company specialising,in cell-based therapies for the ... completed, two months ahead of schedule,enrolment in the ... of C-Cure, a,unique stem cell therapy for heart ...

(Date:12/14/2009)... FREMONT, Calif., Dec. 14 Vermillion, ... company, today announced William C. Wallen, Ph.D. ... and Development for IDEXX Laboratories, will be ... of Vermillion,s bankruptcy plan. ,, "Bill ... development experience in diagnostics and biotechnology," said ...

(Date:12/14/2009)... 14 The third edition of ... , published by the Infusion Nurses Society ... anthracycline extravasation.(1) Anthracyclines are a group of ... that have been used in the treatment of ... ,, According to the INS publication: ...

(Date:12/14/2009)... Nektar Therapeutics (Nasdaq: NKTR ) ... to serve on its board of directors. ... over 35 years of experience in corporate management, ... Nektar extensive industry perspective at an important time ... President and CEO of Nektar and member of ...

Breaking Biology Technology:Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2 Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3 Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2 Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3 Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4 Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2 Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3 Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4 Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5 Dennis Winger Joins Nektar Therapeutics' Board of Directors 2 Dennis Winger Joins Nektar Therapeutics' Board of Directors 3

[0] Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure [0] Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors [0] Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation [0] Dennis Winger Joins Nektar Therapeutics' Board of Directors

... Calif., Oct. 3 Isis,Pharmaceuticals, Inc. (Nasdaq: ... subsidiary, Ibis Biosciences, Inc. (Ibis), was awarded,government ... Department of,Agriculture (USDA), National Institute of Justice ... $8.4 million. These awards will fund the,utilization ...

... releasing natural insect repellents that protect against the Scottish biting midge, ... people protect buildings from unwanted particles, insects, germs and bacteria. ... ... Innovation Ltd has developed a new spray technology that uses no ...

... /Xinhua-PRNewswire-FirstCall/ --,Pharmaceutical company Pharmaxis (ASX: PXS, NASDAQ: PXSL) ... its respiratory disease,program at the 2008 European Respiratory ... 4th to the 8th October. The ERS brings ... clinicians to hear latest,advances in clinical diagnosis and ...

Other Biology Technology:Isis Announces Award of Up to $8.4 Million in New Government Grants and Contracts to Its Ibis Biosciences Subsidiary for Pathogen Detection and Human Forensics 2 Isis Announces Award of Up to $8.4 Million in New Government Grants and Contracts to Its Ibis Biosciences Subsidiary for Pathogen Detection and Human Forensics 3 Isis Announces Award of Up to $8.4 Million in New Government Grants and Contracts to Its Ibis Biosciences Subsidiary for Pathogen Detection and Human Forensics 4 Isis Announces Award of Up to $8.4 Million in New Government Grants and Contracts to Its Ibis Biosciences Subsidiary for Pathogen Detection and Human Forensics 5 New Innovation Set to Revolutionise Spray Technology - Used to Protect Against the Scottish Biting Midge & Help Fight MRSA in the NHS 2 New Innovation Set to Revolutionise Spray Technology - Used to Protect Against the Scottish Biting Midge & Help Fight MRSA in the NHS 3 New Innovation Set to Revolutionise Spray Technology - Used to Protect Against the Scottish Biting Midge & Help Fight MRSA in the NHS 4 Pharmaxis Research Programs Highlighted at European Respiratory Society Congress 2 Pharmaxis Research Programs Highlighted at European Respiratory Society Congress 3

Isis Announces Award of Up to $8.4 Million in New Government Grants and Contracts to Its Ibis Biosciences Subsidiary for Pathogen Detection and Human Forensics New Innovation Set to Revolutionise Spray Technology - Used to Protect Against the Scottish Biting Midge & Help Fight MRSA in the NHS Pharmaxis Research Programs Highlighted at European Respiratory Society Congress

(Date:12/14/2009)... the Biomedical Engineering Society (BMES) have founded a new ... ). CVET is a forum for ... treatment. The first issue of the new quarterly ... other BMES publications at Springer, Annals of Biomedical ... , Cardiovascular Engineering and Technology will present ...

(Date:12/14/2009)... defining feature of humans. That,s until examples of tool use ... array of other mammals. Now, a report in the December ... publication, adds an octopus to the growing list of tool ... trick that the researchers call stilt walking. In it, the ... makes its eight arms rigid, and raises the whole assembly ...

(Date:12/13/2009)... have identified plant enzymes that may help to engineer ... use water more efficiently. The finding could help to ... , Plants take in the carbon dioxide they need ... of leaves. But for each molecule of the gas ... same openings. The pores can tighten to save water ...

[0] Biomedical Engineering Society's new journal to be published by Springer [0] Tool use in an invertebrate: The coconut-carrying octopus [0] Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops

... New York University Biologist Richard Bonneau has been named ... 40 by Discover magazine. Bonneau, 33, is ... for Genomics and Systems Biology and the university,s Courant ... Science 2008," appears in Discover,s December issue. ...

... new study led by researchers at the University of ... supplements can lower concentrations of C-reactive protein (CRP), a ... be a powerful predictor of heart disease and diabetes. ... of vitamin E, another antioxidant. , This study comes ...

... researchers have found a way to accurately predict the ... that could result in better management strategies. , ... between river temperature and salmon mortality rate, are published ... and Biochemical Zoology . , While climate change and ...

Other Biology News:NYU biologist Bonneau named among 20 "visionary" scientists under 40 by Discover magazine 2 Vitamin C lowers levels of inflammation biomarker considered predictor of heart disease 2 Vitamin C lowers levels of inflammation biomarker considered predictor of heart disease 3 Vitamin C lowers levels of inflammation biomarker considered predictor of heart disease 4 UBC study establishes formula for predicting climate change impact on salmon stocks 2

NYU biologist Bonneau named among 20 "visionary" scientists under 40 by Discover magazine Vitamin C lowers levels of inflammation biomarker considered predictor of heart disease UBC study establishes formula for predicting climate change impact on salmon stocks

Qa-1 (L-12)...

... Contains the following: , Coated Capture Antibody: 12 ... Wash/Sample Diluent: 300 mL of 2X concentrate , ... microg lyophilized peptide , Lyophilized Standard Diluent: 3 ... concentrate , Secondary Antibody-HRP: 30 microL of concentrate ...

Peptide Sequence: ovine COX-1 amino acids 272-282 (LMHYPRGIPPQ) To be used in conjunction with Cayman's COX-1 (ovine) polyclonal antiserum (Catalog No. 160108) to block protein-antibody complex f...

Laminin beta-1/gamma-1 (612C10)...

Biology Products:

Goat Anti-Qa-1 (L-12) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.beta-Amyloid 1-40 ELISA Kit (SIGNET) from Covance Research Products, Inc COX-1 Blocking Peptide from Cayman Chemical Mouse Anti-Human Laminin beta-1 / gamma-1 complex Monoclonal Antibody, Unconjugated, Clone 612C10 from Santa Cruz Biotechnology, Inc.

Leading Pharmaceutical Communication Executives Gather for the 1st Annual Pharmaceutical Public Relations...(/p About ExL Pharma ExL Pharma a di...)